{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-284671","form_type":"8-K","ticker":"TCRX","cik":"0001783328","company_name":"TScan Therapeutics, Inc.","filed_at":"2024-12-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.607054+00:00","generated_at":"2026-05-28T23:20:49.303944+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"TScan Therapeutics raises $30M via registered direct offering of pre-funded warrants to Lynx1 Capital","bullets":["Entered securities purchase agreement for pre-funded warrants to purchase 7.5M shares at $4.00 per warrant, gross proceeds ~$30M.","Purchaser is Lynx1 Capital Management LP and an affiliated fund, an existing shareholder.","Net proceeds ~$29.8M for general corporate purposes; closing expected Dec 27, 2024.","Cash runway extended into Q1 2027 based on net proceeds."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-284671","json":"https://secwatch.observer/filing/0001193125-24-284671.json","markdown":"https://secwatch.observer/filing/0001193125-24-284671.md","text":"https://secwatch.observer/filing/0001193125-24-284671.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1783328/000119312524284671/0001193125-24-284671-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1783328/000119312524284671/d861236d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T23:20:49.303944+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}